readthroughSign in
CompanyIMCRNasdaqOxfordshire, X0

Immunocore Ltd

Immunocore develops ImmTAX, a platform of TCR bispecific immunotherapies for cancer, autoimmune diseases, and infectious diseases.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 9Latest story